| Vaccine | Company | Generation | Strain | Growing procedure | Other information | Trial(s) |
| Dryvax | Wyeth | First | NYCBOH | Calf lymph derived | Lyophilized, about 15 million doses stock | Frey 2002a, Frey 2002b, Frey 2003 |
| APSV | Aventis Pasteur | First | NYCBOH | Calf lymph derived | Frozen, about 85 million doses stock | Rock 2004, Talbot 2004 |
| Lancy‐vaxina | Berna Biotech | First | Lister | Calf lymph derived | Lyophilised | Kim 2005 |
| ACAM | Acambis | Second | NYCBOH | Cell culture | MRC‐5 cells (human diploid fibroblasts) | Artenstein 2005 (ACAM2000), Weltzin 2003 (ACAM1000) |
| CCSV | Dynport | Second | NYCBOH | Cell culture | MRC‐5 cells (human diploid fibroblasts) | Greenberg 2005 |
| Lister/Elstree | CDC Taiwan | First | Lister | Calf lymph derived | Lyophilized | Hsieh 2006 |